Whitney Ijem
Stock Analyst at Canaccord Genuity
(3.27)
# 955
Out of 4,896 analysts
101
Total ratings
47.67%
Success rate
2.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VERV Verve Therapeutics | Downgrades: Hold | $39 → $13 | $11.03 | +17.86% | 6 | Jun 17, 2025 | |
TSHA Taysha Gene Therapies | Maintains: Buy | $9 → $11 | $2.64 | +316.67% | 10 | Jun 3, 2025 | |
RCKT Rocket Pharmaceuticals | Maintains: Buy | $34 → $11 | $2.96 | +271.62% | 8 | Jun 3, 2025 | |
NTLA Intellia Therapeutics | Maintains: Buy | $74 → $54 | $11.54 | +368.14% | 6 | Jun 3, 2025 | |
PVLA Palvella Therapeutics | Maintains: Buy | $53 → $52 | $26.50 | +96.23% | 3 | May 16, 2025 | |
ARCT Arcturus Therapeutics Holdings | Maintains: Buy | $68 → $66 | $13.78 | +378.96% | 6 | May 13, 2025 | |
RYTM Rhythm Pharmaceuticals | Maintains: Buy | $81 → $92 | $86.70 | +6.11% | 7 | Apr 8, 2025 | |
ALNY Alnylam Pharmaceuticals | Maintains: Buy | $385 → $390 | $314.94 | +23.83% | 8 | Mar 21, 2025 | |
GBIO Generation Bio Co. | Maintains: Buy | $9 | $0.39 | +2,229.19% | 2 | Mar 17, 2025 | |
TNYA Tenaya Therapeutics | Maintains: Buy | $18 → $6 | $0.68 | +778.22% | 6 | Mar 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $121 → $136 | $29.51 | +360.86% | 8 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $408 → $424 | $468.85 | -9.57% | 8 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 | $0.40 | +3,142.70% | 6 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $148 → $150 | $18.17 | +725.54% | 3 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $84 | $58.10 | +44.58% | 8 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $109.64 | - | 2 | Jan 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $120 → $240 | $4.55 | +5,174.73% | 4 | Jul 23, 2019 |
Verve Therapeutics
Jun 17, 2025
Downgrades: Hold
Price Target: $39 → $13
Current: $11.03
Upside: +17.86%
Taysha Gene Therapies
Jun 3, 2025
Maintains: Buy
Price Target: $9 → $11
Current: $2.64
Upside: +316.67%
Rocket Pharmaceuticals
Jun 3, 2025
Maintains: Buy
Price Target: $34 → $11
Current: $2.96
Upside: +271.62%
Intellia Therapeutics
Jun 3, 2025
Maintains: Buy
Price Target: $74 → $54
Current: $11.54
Upside: +368.14%
Palvella Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $53 → $52
Current: $26.50
Upside: +96.23%
Arcturus Therapeutics Holdings
May 13, 2025
Maintains: Buy
Price Target: $68 → $66
Current: $13.78
Upside: +378.96%
Rhythm Pharmaceuticals
Apr 8, 2025
Maintains: Buy
Price Target: $81 → $92
Current: $86.70
Upside: +6.11%
Alnylam Pharmaceuticals
Mar 21, 2025
Maintains: Buy
Price Target: $385 → $390
Current: $314.94
Upside: +23.83%
Generation Bio Co.
Mar 17, 2025
Maintains: Buy
Price Target: $9
Current: $0.39
Upside: +2,229.19%
Tenaya Therapeutics
Mar 13, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $0.68
Upside: +778.22%
Feb 18, 2025
Maintains: Buy
Price Target: $121 → $136
Current: $29.51
Upside: +360.86%
Feb 12, 2025
Upgrades: Hold
Price Target: $408 → $424
Current: $468.85
Upside: -9.57%
Nov 14, 2024
Maintains: Buy
Price Target: $13
Current: $0.40
Upside: +3,142.70%
Nov 7, 2024
Maintains: Buy
Price Target: $148 → $150
Current: $18.17
Upside: +725.54%
Oct 30, 2024
Maintains: Hold
Price Target: $93 → $84
Current: $58.10
Upside: +44.58%
Jan 21, 2020
Downgrades: Neutral
Price Target: n/a
Current: $109.64
Upside: -
Jul 23, 2019
Upgrades: Overweight
Price Target: $120 → $240
Current: $4.55
Upside: +5,174.73%